iPSC reprogramming involves converting somatic cells into induced pluripotent stem cells (iPSCs) using various delivery methods, including viral vectors, episomal vectors, and mRNA-based approaches. These techniques enable the generation of patient-specific iPSCs for applications in disease modeling, drug discovery, and regenerative medicine. Optimized reprogramming strategies enhance efficiency and safety, ensuring high-quality iPSC lines for research and clinical use.
